Extendicare Inc. (EXETF) Q2 2025 Earnings Call Transcript

Extendicare Inc. reported robust Q2 2025 results, with adjusted EBITDA up 15.4% and AFFO per share rising 23.1% year-over-year to $0.29, driven by strong organic growth and strategic acquisitions. Key transactions included the acquisition of nine long-term care homes from Revera, adding 822 beds and bolstering the redevelopment pipeline, and the $75.1 million acquisition of 'Closing the Gap,' expected to add 1.1 million service hours and $9.8 million in annualized NOI to the home health segment. The company highlighted its disciplined capital allocation, including a $100 million credit facility upsizing and a self-funding joint venture model for its $570 million long-term care redevelopment program, which is further supported by Ontario's new, more flexible capital funding policy, positioning Extendicare to capitalize on increasing demographic-driven demand for seniors' care services.

Analysis

Extendicare Inc. reported a robust second quarter for 2025, demonstrating significant operational momentum and successful execution of its strategic growth plan. Adjusted EBITDA, excluding prior-year out-of-period items, increased by 15.4% to $39.8 million, while AFFO per share surged 23.1% to $0.29. This performance was primarily driven by the Home Health Care segment, which saw average daily volumes rise 10.9% and NOI margins expand by 90 basis points to 13.5%, underscoring the operating leverage from its scalable technology platform. The company's growth is being augmented by disciplined M&A, with the acquisitions of nine Revera long-term care (LTC) homes and home care provider 'Closing the Gap' expected to add a combined annualized NOI of approximately $16.6 million, with the full financial impact beginning in Q3 2025. A key forward-looking catalyst is the new Ontario government LTC capital funding policy, which provides greater funding flexibility and long-term certainty, enabling Extendicare to accelerate its redevelopment pipeline. The company's self-funding joint venture model for its $570 million redevelopment program, combined with a strong liquidity position following a $100 million credit facility expansion, positions it to capitalize on demographic tailwinds and further M&A opportunities in a fragmented market.

Key Decisions for Investors

• Investors should update models to reflect the full quarterly impact of the Revera and Closing the Gap acquisitions starting in Q3 2025, which are guided to add a combined $0.08 to annualized AFFO per share.
• The new Ontario long-term care funding policy is a significant positive catalyst; monitor the company's progress towards its goal of initiating one new redevelopment project in 2025 and up to three in 2026, as this will be a key driver of long-term value.
• While the 13.5% NOI margin in home health care is a high point, anticipate seasonal margin softness in Q3 and Q4 as guided by management, but look for post-integration synergies of $1.1 million from the Closing the Gap acquisition to support margin strength into 2026.
• Given the company's strong liquidity and stated appetite for further acquisitions, attention should be paid to future capital deployment, particularly in the fragmented home care space, as a source of potential upside.